ANNA D PENDLETON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner KINGSPORT, TN NPI 1235158643
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TN Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$709.71
- Category: General Payments
- Program years: PY2021–2023
- Record count: 32
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $142.41 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.41 | 6 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $62.91 | 1 |
| Daxor Corporation | $32.82 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.77 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.07 | 1 |
| Acerta Pharma LLC | $13.84 | 1 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1015873339 | AstraZeneca Pharmaceuticals LP | $13.84 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1016137951 | E.R. Squibb & Sons, L.L.C. | $15.07 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048550003 | Merck Sharp & Dohme LLC | $62.91 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1052103561 | Daxor Corporation | $15.84 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1052103565 | Daxor Corporation | $16.98 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 992905277 | Novartis Pharmaceuticals Corporation | $17.77 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.